Cargando…

Short-Term Western Diet Aggravates Non-Alcoholic Fatty Liver Disease (NAFLD) With Portal Hypertension in TGR(mREN2)27 Rats

Non-alcoholic fatty liver disease (NAFLD) is gaining in importance and is linked to obesity. Especially, the development of fibrosis and portal hypertension in NAFLD patients requires treatment. Transgenic TGR(mREN2)27 rats overexpressing mouse renin spontaneously develop NAFLD with portal hypertens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cremonese, Carla, Schierwagen, Robert, Uschner, Frank Erhard, Torres, Sandra, Tyc, Olaf, Ortiz, Cristina, Schulz, Martin, Queck, Alexander, Kristiansen, Glen, Bader, Michael, Sauerbruch, Tilman, Weiskirchen, Ralf, Walther, Thomas, Trebicka, Jonel, Klein, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7246932/ https://www.ncbi.nlm.nih.gov/pubmed/32392802 http://dx.doi.org/10.3390/ijms21093308

Ejemplares similares

TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor
por: Klein, Sabine, et al.
Publicado: (2019)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

β-Arrestin2 is increased in liver fibrosis in humans and rodents
por: Schierwagen, Robert, et al.
Publicado: (2020)

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?
por: Sauerbruch, Tilman, et al.
Publicado: (2023)

Future therapy of portal hypertension in liver cirrhosis – a guess
por: Sauerbruch, Tilman, et al.
Publicado: (2014)

Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
por: Uschner, Frank E., et al.
Publicado: (2015)

Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS
por: Queck, Alexander, et al.
Publicado: (2020)

Characterization of the Cardiac Renin Angiotensin System in Oophorectomized and Estrogen-Replete mRen2.Lewis Rats
por: Wang, Hao, et al.
Publicado: (2013)

Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
por: Klein, Sabine, et al.
Publicado: (2015)

Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension
por: Klein, Sabine, et al.
Publicado: (2016)

Pre-primary and Primary Prophylaxis of Variceal Hemorrhage
por: Sauerbruch, Tilman, et al.
Publicado: (2013)

Angiotensin-(1-7) Central Mechanisms After ICV Infusion in Hypertensive Transgenic (mRen2)27 Rats
por: Kangussu, Lucas M., et al.
Publicado: (2021)

The Role of miRNA-34a as a Prognostic Biomarker for Cirrhotic Patients with Portal Hypertension Receiving TIPS
por: Jansen, Christian, et al.
Publicado: (2014)

Pathophysiological role of prostanoids in coagulation of the portal venous system in liver cirrhosis
por: Queck, Alexander, et al.
Publicado: (2019)

Functional Significance of Angiotensin Receptor Type 2 in the Neuroplasticity of Autonomic Ganglia in (mRen2)27 Transgenic Hypertensive Rats
por: Swami Vetha, Berwin Singh, et al.
Publicado: (2022)

Baseline Presence of NAFLD Predicts Weight Loss after Gastric Bypass Surgery for Morbid Obesity
por: Rheinwalt, Karl Peter, et al.
Publicado: (2020)

The multikinase inhibitor regorafenib decreases angiogenesis and improves portal hypertension
por: Uschner, Frank Erhard, et al.
Publicado: (2018)

Hepatic inflammasome activation as origin of Interleukin-1α and Interleukin-1β in liver cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2021)

Role of circulating angiogenin levels in portal hypertension and TIPS
por: Queck, Alexander, et al.
Publicado: (2021)

Attenuation of Salt-Induced Cardiac Remodeling and Diastolic Dysfunction by the GPER Agonist G-1 in Female mRen2.Lewis Rats
por: Jessup, Jewell A., et al.
Publicado: (2010)

Combined Renin Inhibition/(Pro)Renin Receptor Blockade in Diabetic Retinopathy- A Study in Transgenic (mREN2)27 Rats
por: Batenburg, Wendy W., et al.
Publicado: (2014)

Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction
por: Sauerbruch, Tilman, et al.
Publicado: (2021)

Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats
por: Klein, Sabine, et al.
Publicado: (2019)

Acute and chronic systemic CB(1) cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats
por: Schaich, Chris L., et al.
Publicado: (2014)

Serum markers of the extracellular matrix remodeling reflect antifibrotic therapy in bile-duct ligated rats
por: Schierwagen, Robert, et al.
Publicado: (2013)

Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
por: Liedtke, Christian, et al.
Publicado: (2013)

Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis
por: Praktiknjo, Michael, et al.
Publicado: (2020)

A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic Steatosis
por: Schierwagen, Robert, et al.
Publicado: (2020)

Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis
por: Schierwagen, Robert, et al.
Publicado: (2015)

Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview
por: Torres, Sandra, et al.
Publicado: (2020)

Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in Cirrhosis
por: Queck, Alexander, et al.
Publicado: (2020)

Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice
por: Huss, Sebastian, et al.
Publicado: (2013)

Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018)
por: Gu, Wenyi, et al.
Publicado: (2021)

Soluble TNF-Alpha-Receptors I Are Prognostic Markers in TIPS-Treated Patients with Cirrhosis and Portal Hypertension
por: Trebicka, Jonel, et al.
Publicado: (2013)

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease
por: Tyc, Olaf, et al.
Publicado: (2020)

Editorial: Acute-on-chronic liver failure: systemic inflammation and immunosuppression
por: Tyc, Olaf, et al.
Publicado: (2023)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

Etiology and Complications of Portal Vein Thrombosis
por: Trebicka, Jonel, et al.
Publicado: (2014)

TGR5 regulates portal perfusion pressure of the liver
por: Ghallab, Ahmed
Publicado: (2019)

The Role of Macrophage-Inducible C-Type Lectin in Different Stages of Chronic Liver Disease
por: Schierwagen, Robert, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h6521vjusc9apq8odpel227l3n